4//SEC Filing
Flynn Paul R 4
Accession 0001093557-21-000115
CIK 0001093557other
Filed
Apr 15, 8:00 PM ET
Accepted
Apr 16, 4:44 PM ET
Size
4.9 KB
Accession
0001093557-21-000115
Insider Transaction Report
Form 4
DEXCOM INCDXCM
Flynn Paul R
EVP, Global Revenue
Transactions
- Sale
Common Stock
2021-04-15$400.00/sh−758$303,200→ 12,306 total
Footnotes (2)
- [F1]On December 11, 2020, Mr. Flynn adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Flynn. The shares set forth above were sold pursuant to the 10b5-1 Plan.
- [F2]Included in this number are 12,306 unvested restricted stock units, 5,634 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 3,916 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 2,756 of which were granted on March 8, 2019 and shall vest through March 8, 2022.
Documents
Issuer
DEXCOM INC
CIK 0001093557
Entity typeother
Related Parties
1- filerCIK 0001850141
Filing Metadata
- Form type
- 4
- Filed
- Apr 15, 8:00 PM ET
- Accepted
- Apr 16, 4:44 PM ET
- Size
- 4.9 KB